U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 55

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:763804-763805
GRCh38:
Chr11:763804-763805
TALDO1I232fsDeficiency of transaldolaseLikely pathogeniccriteria provided, single submitter
2.
GRCh37:
Chr11:763394
GRCh38:
Chr11:763394
LOC126861110, TALDO1S171FDeficiency of transaldolaseLikely pathogenicno assertion criteria provided
3.
GRCh37:
Chr11:763450
GRCh38:
Chr11:763450
LOC126861110, TALDO1V190FDeficiency of transaldolaseUncertain significance
(Dec 22, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr11:763751-763752
GRCh38:
Chr11:763751-763752
LOC126861110, TALDO1K215fsnot provided, Deficiency of transaldolasePathogenic
(Dec 30, 2021)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr11:764323
GRCh38:
Chr11:764323
TALDO1E291Knot provided, Deficiency of transaldolaseUncertain significance
(Jul 24, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr11:760112-760122
GRCh38:
Chr11:760112-760122
TALDO1Deficiency of transaldolaseUncertain significance
(Apr 20, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr11:764813
GRCh38:
Chr11:764813
TALDO1E328KDeficiency of transaldolaseUncertain significance
(May 5, 2020)
criteria provided, single submitter
8.
GRCh37:
Chr11:764340
GRCh38:
Chr11:764340
TALDO1W296*Deficiency of transaldolaseUncertain significance
(Jun 8, 2020)
criteria provided, single submitter
9.
GRCh37:
Chr11:763778
GRCh38:
Chr11:763778
LOC126861110, TALDO1Y223*Deficiency of transaldolasePathogenic
(Jun 2, 2020)
no assertion criteria provided
10.
GRCh37:
Chr11:764336
GRCh38:
Chr11:764336
TALDO1R295HDeficiency of transaldolaseUncertain significance
(Apr 1, 2020)
criteria provided, single submitter
11.
GRCh37:
Chr11:763340
GRCh38:
Chr11:763340
LOC126861110, TALDO1not provided, Deficiency of transaldolaseConflicting interpretations of pathogenicity
(Jul 12, 2022)
criteria provided, conflicting interpretations
12.
GRCh37:
Chr11:760148
GRCh38:
Chr11:760148
TALDO1V119ADeficiency of transaldolaseUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr11:747476
GRCh38:
Chr11:747476
TALDO1Deficiency of transaldolaseUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr11:764408
GRCh38:
Chr11:764408
TALDO1A319VDeficiency of transaldolaseUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr11:763893
GRCh38:
Chr11:763893
TALDO1E262QDeficiency of transaldolase, not providedUncertain significance
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr11:763815
GRCh38:
Chr11:763815
TALDO1A236TDeficiency of transaldolase, not providedUncertain significance
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr11:763362
GRCh38:
Chr11:763362
LOC126861110, TALDO1Deficiency of transaldolase, not providedUncertain significance
(May 30, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr11:763824
GRCh38:
Chr11:763824
TALDO1R239GDeficiency of transaldolasePathogenic
(Feb 1, 2020)
no assertion criteria provided
19.
GRCh37:
Chr11:763486
GRCh38:
Chr11:763486
LOC126861110, TALDO1D202Nnot providedUncertain significance
(Jul 21, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr11:747517
GRCh38:
Chr11:747517
TALDO1not provided, Deficiency of transaldolaseConflicting interpretations of pathogenicity
(Oct 30, 2022)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr11:764382
GRCh38:
Chr11:764382
TALDO1not provided, Deficiency of transaldolaseConflicting interpretations of pathogenicity
(Jul 30, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr11:760201
GRCh38:
Chr11:760201
TALDO1D137YDeficiency of transaldolasenot providedno assertion provided
23.
GRCh37:
Chr11:764383
GRCh38:
Chr11:764383
TALDO1G311WDeficiency of transaldolasePathogenic
(Jun 2, 2020)
no assertion criteria provided
24.
GRCh37:
Chr11:763457
GRCh38:
Chr11:763457
TALDO1, LOC126861110R192Hnot provided, Deficiency of transaldolaseConflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr11:763456
GRCh38:
Chr11:763456
LOC126861110, TALDO1R192Cnot provided, Deficiency of transaldolasePathogenic
(Sep 11, 2023)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr11:765037
GRCh38:
Chr11:765037
TALDO1Deficiency of transaldolaseLikely benign
(Jun 14, 2016)
criteria provided, single submitter
27.
GRCh37:
Chr11:764878
GRCh38:
Chr11:764878
TALDO1Deficiency of transaldolaseUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr11:764875
GRCh38:
Chr11:764875
TALDO1Deficiency of transaldolaseUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr11:764857
GRCh38:
Chr11:764857
TALDO1Deficiency of transaldolaseUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr11:764854
GRCh38:
Chr11:764854
TALDO1Deficiency of transaldolaseBenign
(Jan 12, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr11:764800-764803
GRCh38:
Chr11:764800-764803
TALDO1not provided, Deficiency of transaldolaseConflicting interpretations of pathogenicity
(Oct 29, 2022)
criteria provided, conflicting interpretations
32.
GRCh37:
Chr11:764423
GRCh38:
Chr11:764423
TALDO1R324QDeficiency of transaldolaseUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
33.
GRCh37:
Chr11:764414
GRCh38:
Chr11:764414
TALDO1K321Rnot provided, Deficiency of transaldolaseBenign/Likely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr11:764404
GRCh38:
Chr11:764404
TALDO1D318NDeficiency of transaldolaseUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr11:763910
GRCh38:
Chr11:763910
TALDO1not provided, Deficiency of transaldolaseBenign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr11:763835
GRCh38:
Chr11:763835
TALDO1not provided, Deficiency of transaldolaseUncertain significance
(Jun 4, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr11:763771
GRCh38:
Chr11:763771
LOC126861110, TALDO1Y221Cnot provided, Deficiency of transaldolaseUncertain significance
(May 28, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr11:763370
GRCh38:
Chr11:763370
LOC126861110, TALDO1H163RDeficiency of transaldolaseUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr11:763358
GRCh38:
Chr11:763358
LOC126861110, TALDO1Q159RInborn genetic diseases, not provided, Deficiency of transaldolase
Conflicting interpretations of pathogenicity
(Nov 17, 2022)
criteria provided, conflicting interpretations
40.
GRCh37:
Chr11:763357
GRCh38:
Chr11:763357
LOC126861110, TALDO1Q159Enot provided, Deficiency of transaldolaseUncertain significance
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr11:760267
GRCh38:
Chr11:760267
TALDO1not provided, Deficiency of transaldolaseConflicting interpretations of pathogenicity
(May 13, 2022)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr11:760194
GRCh38:
Chr11:760194
TALDO1Deficiency of transaldolaseUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr11:759021
GRCh38:
Chr11:759021
TALDO1K98MDeficiency of transaldolaseUncertain significance
(Feb 27, 2018)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr11:755978
GRCh38:
Chr11:755978
TALDO1I66TInborn genetic diseases, not provided, Deficiency of transaldolase
Conflicting interpretations of pathogenicity
(Oct 20, 2022)
criteria provided, conflicting interpretations
45.
GRCh37:
Chr11:755962
GRCh38:
Chr11:755962
TALDO1L61VDeficiency of transaldolase, not providedUncertain significance
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr11:747559
GRCh38:
Chr11:747559
TALDO1Deficiency of transaldolaseUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr11:747549
GRCh38:
Chr11:747549
TALDO1T23SInborn genetic diseases, not provided, Deficiency of transaldolase
Uncertain significance
(Aug 28, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr11:747529
GRCh38:
Chr11:747529
TALDO1Deficiency of transaldolaseUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr11:747452
GRCh38:
Chr11:747452
TALDO1Deficiency of transaldolaseUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
50.
GRCh37:
Chr11:747446-747457
GRCh38:
Chr11:747446-747457
TALDO1Deficiency of transaldolaseLikely benign
(Jun 14, 2016)
criteria provided, single submitter
51.
GRCh37:
Chr11:747445-747446
GRCh38:
Chr11:747445-747446
TALDO1Deficiency of transaldolaseUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
52.
GRCh37:
Chr11:747445
GRCh38:
Chr11:747445
TALDO1Deficiency of transaldolaseUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
53.
GRCh37:
Chr11:763397-763398
GRCh38:
Chr11:763397-763398
LOC126861110, TALDO1A173fsDeficiency of transaldolasePathogenic
(Dec 30, 2014)
criteria provided, single submitter
54.
GRCh37:
Chr11:763902
GRCh38:
Chr11:763902
TALDO1Q265fsnot provided, Deficiency of transaldolasePathogenic
(Aug 18, 2021)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr11:763392-763394
GRCh38:
Chr11:763392-763394
LOC126861110, TALDO1S171delDeficiency of transaldolasePathogenic
(May 1, 2001)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination